691857-54-2

Basic information

• Product Name: 3-Benzofurancarboxylic acid, 5-cyclopropyl-2-(4-fluorophenyl)-6-[(Methylsulfonyl)aMino]-
• Synonyms: 3-Benzofurancarboxylic acid, 5-cyclopropyl-2-(4-fluorophenyl)-6-[(Methylsulfonyl)aMino]-;5-cyclopropyl-2-(4-fluorophenyl)-6-(methylsulfonamido)benzofuran-3-carboxylicacid;3-BENZOFURANCARBOXYLIC ACID, 5-CYCLOPROPYL-2-(4-FLUOROPHENYL)-6-[(METHYLSULFONYL)AMINO]-(WXG02819)
• CAS NO: 691857-54-2
• Molecular Formula: C₁₉H₁₆FNO₅S
• Molecular Weight: 389.3974432
• Mol File: 691857-54-2.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-Benzofurancarboxylic acid, 5-cyclopropyl-2-(4-fluorophenyl)-6-[(Methylsulfonyl)aMino]-(CAS DataBase Reference)
• NIST Chemistry Reference: 3-Benzofurancarboxylic acid, 5-cyclopropyl-2-(4-fluorophenyl)-6-[(Methylsulfonyl)aMino]-(691857-54-2)
• EPA Substance Registry System: 3-Benzofurancarboxylic acid, 5-cyclopropyl-2-(4-fluorophenyl)-6-[(Methylsulfonyl)aMino]-(691857-54-2)

Safety Data

• Hazardous Substances Data: 691857-54-2(Hazardous Substances Data)

Usage

General Description

3-Benzofurancarboxylic acid, 5-cyclopropyl-2-(4-fluorophenyl)-6-[(methylsulfonyl)amino]- is a chemical compound with the molecular formula C22H19FNO4S. It is a derivative of benzo[b]furancarboxylic acid and contains a cyclopropyl, fluorophenyl, and methylsulfonylamino group. 3-Benzofurancarboxylic acid, 5-cyclopropyl-2-(4-fluorophenyl)-6-[(methylsulfonyl)amino]- has potential pharmaceutical applications and may be utilized in the development of new drugs for various medical conditions. Its structural and chemical properties make it a promising candidate for further research and development in the field of medicinal chemistry.

Upstream product

• 691857-55-3 C₂₀H₁₈FNO₇S₂ 
• 63131-29-3 methyl 4-fluorobenzoyl acetate 
• 106-51-4 p-benzoquinone 
• 691856-96-9 methyl 2-(4-fluorophenyl)-5-hydroxy-1-benzofuran-3-carboxylate 
• 1331942-95-0 methyl 2-(4-fluorophenyl)-5-hydroxy-6-nitro-1-benzofuran-3-carboxylate 
• 1331942-96-1 methyl 2-(4-fluorophenyl)-6-nitro-5-{[(trifluoromethyl)sulfonyl]oxy}-1-benzofuran-3-carboxylate 
• 1331942-97-2 methyl 5-cyclopropyl-2-(4-fluorophenyl)-6-nitro-1-benzofuran-3-carboxylate 
• 1331942-98-3 methyl 6-amino-5-cyclopropyl-2-(4-fluorophenyl)-1-benzofuran-3-carboxylate 
• 1331942-99-4 methyl 6-[bis(methylsulfonyl)amino]-5-cyclopropyl-2-(4-fluorophenyl)-1-benzofuran-3-carboxylate 
• 1331942-87-0 methyl 2-(4-fluorophenyl)-5-[(1-methylethyl)oxy]-1-benzofuran-3-carboxylate 
• 1331942-88-1 methyl 2-(4-fluorophenyl)-5-[(1-methylethyl)oxy]-6-nitro-1-benzofuran-3-carboxylate 
• 691856-87-8 ethyl 2-(4-fluorophenyl)-5-isopropoxybenzofuran-3-carboxylate 
• 691857-07-5 ethyl 2-(4-fluorophenyl)-5-isopropoxy-6-nitrobenzofuran-3-carboxylate 
• 691857-46-2 ethyl 2-(4-fluorophenyl)-5-hydroxy-6-nitrobenzofuran-3-carboxylate 

Downstream Products

• 691856-35-6 5-cyclopropyl-2-(4-fluorophenyl)-N-methyl-6-(methylsulfonamido)benzofuran-3-carboxamide 
• 1378429-90-3 N,5-dicyclopropyl-2-(4-fluorophenyl)-6-(methylsulfonamido)benzofuran-3-carboxamide 
• 1378429-37-8 5-cyclopropyl-2-(4-fluorophenyl)-N-isopropyl-6-(methylsulfonamido)benzofuran-3-carboxamide 
• 1378429-41-4 6-(N-(3-(benzyloxy)-2-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)propyl)methylsulfonamido)-5-cyclopropyl-2-(4-fluorophenyl)-N-isopropylbenzofuran-3-carboxamide 
• 1378427-45-2 5-cyclopropyl-2-(4-fluorophenyl)-6-(N-((2-hydroxy-1,2-oxaborolan-4-yl)methyl)methylsulfonamido)-N-isopropylbenzofuran-3-carboxamide 
• 1378429-42-5 N-(2-(benzyloxy)ethyl)-5-cyclopropyl-2-(4-fluorophenyl)-6-(methylsulfonamido)benzofuran-3-carboxamide 
• 1378429-43-6 N-(2-(benzyloxy)ethyl)-6-(N-(2-(benzyloxymethyl)allyl)methylsulfonamido)-5-cyclopropyl-2-(4-fluorophenyl)benzofuran-3-carboxamide 
• 1378429-45-8 6-(N-(3-(benzyloxy)-2-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)propyl)methylsulfonamido)-N-(2-(benzyloxy)ethyl)-5-cyclopropyl-2-(4-fluorophenyl)benzofuran-3-carboxamide 
• 1378427-47-4 5-cyclopropyl-2-(4-fluorophenyl)-6-(N-((2-hydroxy-1,2-oxaborolan-4-yl)methyl)methylsulfonamido)-N-(2-hydroxyethyl)benzofuran-3-carboxamide 
• 1378429-71-0 6-[[(2Z)-3-bromo-2-({[(methyloxy)methyl]oxy}methyl)-2-propen-1-yl](methylsulfonyl)amino]-5-cyclopropyl-2-(4-fluorophenyl)-N-methyl-1-benzofuran-3-carboxamide 
• 1378427-52-1 5-cyclopropyl-2-(4-fluorophenyl)-6-[[(2-hydroxy-2,5-dihydro-1,2-oxaborol-4-yl)methyl](methylsulfonyl)amino]-N-methyl-1-benzofuran-3-carboxamide 
• 1378429-93-6 6-(N-(2-(benzyloxymethyl)allyl)methylsulfonamido)-N,5-dicyclopropyl-2-(4-fluorophenyl)benzofuran-3-carboxamide 
• 1378429-95-8 6-(N-(3-(benzyloxy)-2-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)methyl)propyl)methylsulfonamido)-N,5-dicyclopropyl-2-(4-fluorophenyl)benzofuran-3-carboxamide 
• 1378427-57-6 N,5-dicyclopropyl-2-(4-fluorophenyl)-6-(N-((2-hydroxy-1,2-oxaborolan-4-yl)methyl)methylsulfonamido)benzofuran-3-carboxamide 

Relevant articles and documents

Convergent Synthesis of the NS5B Inhibitor GSK8175 Enabled by Transition Metal Catalysis

A convergent eight-stage synthesis of the boron-containing NS5B inhibitor GSK8175 is described. The previous route involves 13 steps in a completely linear sequence, with an overall 10% yield. Key issues include a multiday SNAr arylation of a s

THERAPEUTIC METHODS

The present invention features a method for the treatment of Hepatitis C in a human in need thereof comprising administering a compound of Formulas (II) or (IIB) described herein or a pharmaceutically acceptable salt thereof in combination with one or more alternative Hepatitis C therapeutic agents

COMPOUNDS

The present invention features compounds of formula (I): and salts thereof, pharmaceutical compositions comprising said compounds, and uses of such compounds in treating or preventing viral infections, such as HCV infections, and diseases associated with such infections.